These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity. Than KW; Okayasu I; Akashi T Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960 [TBL] [Abstract][Full Text] [Related]
25. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis. van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213 [TBL] [Abstract][Full Text] [Related]
26. Argyrophilic nucleolar organizer regions and alpha-fetoprotein in adenomatous hyperplasia in human cirrhotic livers. Terasaki S; Terada T; Nakanuma Y; Nonomura A; Unoura M; Kobayashi K Am J Clin Pathol; 1991 Jun; 95(6):850-7. PubMed ID: 1710418 [TBL] [Abstract][Full Text] [Related]
27. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen. Terada T; Nakanuma Y Cancer; 1992 Aug; 70(3):591-8. PubMed ID: 1352480 [TBL] [Abstract][Full Text] [Related]
28. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Takashima T; Nakanuma Y; Unoura M; Kobayashi K; Izumi R; Ida M Radiology; 1991 Feb; 178(2):493-7. PubMed ID: 1846240 [TBL] [Abstract][Full Text] [Related]
29. Incidence of adenomatous hyperplasia in postmortem cirrhotic livers and study of cellular proliferative indices by light microscopy. Vaiphei K; Ghosh UK; Vasishta RK Indian J Gastroenterol; 1999; 18(1):7-10. PubMed ID: 10063738 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma. Choi WT; Kakar S Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367 [TBL] [Abstract][Full Text] [Related]
33. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. Borzio M; Borzio F; Croce A; Sala M; Salmi A; Leandro G; Bruno S; Roncalli M Gastroenterology; 1997 May; 112(5):1617-23. PubMed ID: 9136841 [TBL] [Abstract][Full Text] [Related]
34. Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis. Hsu CY; Chu CH; Lin SC; Yang FS; Yang TL; Chang KM World J Gastroenterol; 2003 Mar; 9(3):627-30. PubMed ID: 12632534 [TBL] [Abstract][Full Text] [Related]
35. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Ueda K; Terada T; Nakanuma Y; Matsui O Hum Pathol; 1992 Jun; 23(6):619-26. PubMed ID: 1317345 [TBL] [Abstract][Full Text] [Related]
36. [The role of laparoscopy and laparoscopic ultrasonography in the diagnosis and differential diagnosis of nodular hepatocellular lesions]. Krastev N; Grigorov N; Dinkov L; Genov Y; Mitova R; Donov M Khirurgiia (Sofiia); 1998; 53(6):14-8. PubMed ID: 11247062 [TBL] [Abstract][Full Text] [Related]
37. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma]. DU JL; Wei LX; Wang YL Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352 [TBL] [Abstract][Full Text] [Related]
39. Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers. Hoso M; Nakanuma Y Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):401-4. PubMed ID: 1852083 [TBL] [Abstract][Full Text] [Related]
40. Huge adenomatous hyperplasia of the liver. Chen LK; Chang FC; Lai CR; Luo JC; Tsai ST; Hwang SJ J Clin Gastroenterol; 2002 Mar; 34(3):272-4. PubMed ID: 11873111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]